LGF
TEVA icon

LGT Group Foundation’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

LGT Group Foundation’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-101,000
Closed -$815K – 272
2022
Q3 		$815K Hold
101,000
– – 0.03% 203
2022
Q2 		$760K Hold
101,000
– – 0.02% 210
2022
Q1 		$948K Hold
101,000
– – 0.02% 218
2021
Q4 		$809K Buy
+101,000
New +$912K 0.02% 213

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

LGT Group Foundation's TEVA Position: Q4 2022 in Review

LGT Group Foundation sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2022, closing a stake of 101,000 shares — an estimated $815K sold.

LGT Group Foundation first reported a position in TEVA in Q4 2021 and held it in 4 quarters. The position peaked at $948K in Q1 2022. 421 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • LGT Group Foundation reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2022 after selling out during the quarter.
  • LGT Group Foundation sold 101,000 Teva Pharmaceutical Industries Limited shares in Q4 2022, an estimated $815K.
  • LGT Group Foundation first reported a position in Teva Pharmaceutical Industries Limited in Q4 2021 and held it in 4 quarters.
  • LGT Group Foundation's Teva Pharmaceutical Industries Limited position peaked at $948K in Q1 2022.
  • 421 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2022.

Based on LGT Group Foundation's 13F filing for Q4 2022, filed 9 Feb 2023.